Spectrum Instrumentation has introduced a Direct Digital Synthesis (DDS) option for its 65xx series Arbitrary Waveform ...

GEORGIA — Braves Country can catch all this season’s action on Spectrum. The Braves and Spectrum have entered a multiyear distribution agreement to provide the newly announced BravesVision network to ...

ANGOLA — Gaming tax receipts in Steuben County would be approximately the same as those identified in a theoretical study conducted by the state last fall that led to the eventual legislation that put ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Claude can now generate visuals when producing a response. (Anthropic) With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its ...

As satellite communications constellations grow in size and number, they are also competing for a scarce and increasingly valuable resource: spectrum, the bands of radio frequencies that are crucial ...

Generate:Biomedicines has hit the public markets as the world begins to question the usefulness of AI technology. CEO Mike Nally says biology is the key to unlocking the technology’s full potential.

Generate Biomedicines shares dropped nearly 21% Friday after the company’s $400 million initial public offering, continuing an uneven recovery for biotech stock-market debuts. After a biotech IPO ...

Generate Biomedicines Inc. shares slumped 21% in the company’s trading debut after it raised $400 million in an initial public offering. Shares of the Somerville, Massachusetts-based drug developer ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...